chr21-28883046-A-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4BP6_Moderate
The NM_013240.6(N6AMT1):āc.160T>Gā(p.Ser54Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,452,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_013240.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
N6AMT1 | NM_013240.6 | c.160T>G | p.Ser54Ala | missense_variant | 2/6 | ENST00000303775.10 | |
N6AMT1 | NM_182749.5 | c.160T>G | p.Ser54Ala | missense_variant | 2/5 | ||
N6AMT1 | NR_047510.3 | n.182T>G | non_coding_transcript_exon_variant | 2/7 | |||
N6AMT1 | XR_007067787.1 | n.182T>G | non_coding_transcript_exon_variant | 2/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
N6AMT1 | ENST00000303775.10 | c.160T>G | p.Ser54Ala | missense_variant | 2/6 | 1 | NM_013240.6 | P1 | |
N6AMT1 | ENST00000351429.7 | c.160T>G | p.Ser54Ala | missense_variant | 2/5 | 1 | |||
N6AMT1 | ENST00000460212.1 | c.160T>G | p.Ser54Ala | missense_variant, NMD_transcript_variant | 2/7 | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 247942Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134202
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1452784Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 722688
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at